Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Molecular glues for protein-protein interactions: Progressing toward a new dream
Markella Konstantinidou, Michelle R. Arkin
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1064-1088
Open Access | Times Cited: 25
Proteome-scale discovery of protein degradation and stabilization effectors
Juline Poirson, Hanna Cho, Akashdeep Dhillon, et al.
Nature (2024) Vol. 628, Iss. 8009, pp. 878-886
Closed Access | Times Cited: 24
Exploring the chemical space of orally bioavailable PROTACs
Giulia Apprato, Vasanthanathan Poongavanam, Diego García Jiménez, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103917-103917
Open Access | Times Cited: 18
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Confounding Factors in Targeted Degradation of Short-Lived Proteins
Vesna Vetma, Laura Casares Perez, J. E. Elias, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 7, pp. 1484-1494
Open Access | Times Cited: 12
Structural and Physicochemical Features of Oral PROTACs
Markus Schade, James S. Scott, Thomas G. Hayhow, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 13106-13116
Closed Access | Times Cited: 12
Benchmarking Methods for PROTAC Ternary Complex Structure Prediction
Evianne Rovers, Matthieu Schapira
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 15, pp. 6162-6173
Closed Access | Times Cited: 12
Degraders in epigenetic therapy: PROTACs and beyond
Xing‐Jie Dai, Shi‐Kun Ji, Meng‐Jie Fu, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1464-1499
Open Access | Times Cited: 11
ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation
Eslam M.H. Ali, Cody Loy, Darci J. Trader
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10
RNATACs: Multispecific small molecules targeting RNA by induced proximity
Yan Song, Jia Cui, Jiaqiang Zhu, et al.
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1101-1117
Open Access | Times Cited: 10
Innovative, combinatorial and high-throughput approaches to degrader synthesis
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 9
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
Florian Wittlinger, Blessing C. Ogboo, Ekaterina Shevchenko, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8
Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human Cancers
Lin Yang, Wenbin Tu, Lingying Leng, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Modulating the phosphorylation status of target proteins through bifunctional molecules
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access | Times Cited: 1
Rezatapopt (PC14586): A First-in-Class Small Molecule p53 Y220C Mutant Protein Stabilizer in Clinical Trials
Zonghui Ma, Qiang Shen, Jia Zhou
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
The expanding repertoire of covalent warheads for drug discovery
Namrashee V. Mehta, Mariam S. Degani
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103799-103799
Closed Access | Times Cited: 20
Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACs
Rebecca Stevens, Enrique Bendito-Moll, David Battersby, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15437-15452
Closed Access | Times Cited: 18
Accelerating PROTACs Discovery Through a Direct‐to‐Biology Platform Enabled by Modular Photoclick Chemistry
Ke‐Nian Yan, Yong‐Qiang Nie, Jiayu Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 7
An updated patent review of BRD4 degraders
Zonghui Ma, Cun Zhang, Andrew A. Bolinger, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 929-951
Closed Access | Times Cited: 6
Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists?
Anna Pasieka, Eleonora Diamanti, Elisa Uliassi, et al.
ChemMedChem (2023) Vol. 18, Iss. 20
Open Access | Times Cited: 14
Discovery of Molecular Glue Degraders via Isogenic Morphological Profiling
Amanda Hui Qi Ng, Fabian Offensperger, José A. Cisneros, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 12, pp. 2464-2473
Open Access | Times Cited: 13
Confounding factors in targeted degradation of short-lived proteins
Vesna Vetma, Laura Casarez-Perez, J. E. Elias, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Molecular Glue-Mediated Targeted Protein Degradation: A Novel Strategy in Small-Molecule Drug Development
Xueqiang Tan, Zuyi Huang, Hairun Pei, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110712-110712
Open Access | Times Cited: 5
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
Use of Aldehyde–Alkyne–Amine Couplings to Generate Medicinal Chemistry-Relevant Linkers
Andrew McGown, Vesna Vetma, Damien Crépin, et al.
ACS Medicinal Chemistry Letters (2025)
Open Access
Page 1 - Next Page

Scroll to top